Whole genome sequencing in psychiatric disorders: the WGSPD consortium

As technology advances, whole genome sequencing (WGS) is likely to supersede other genotyping technologies. The rate of this change depends on its relative cost and utility. Variants identified uniquely through WGS may reveal novel biological pathways underlying complex disorders and provide high-resolution insight into when, where, and in which cell type these pathways are affected. Alternatively, cheaper and less computationally intensive approaches may yield equivalent insights. Understanding the role of rare variants in the noncoding gene-regulating genome through pilot WGS projects will be critical to determining which of these two extremes best represents reality. With large cohorts, well-defined risk loci, and a compelling need to understand the underlying biology, psychiatric disorders have a role to play in this preliminary WGS assessment. The Whole Genome Sequencing for Psychiatric Disorders Consortium will integrate data for 18,000 individuals with psychiatric disorders, beginning with autism spectrum disorder, schizophrenia, bipolar disorder, and major depressive disorder, along with over 150,000 controls.

[1]  Andres Metspalu,et al.  Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population , 2014, PLoS genetics.

[2]  Deciphering Developmental Disorders Study,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[3]  Florian Holsboer,et al.  Phenotypic association analyses with copy number variation in recurrent depressive disorder , 2015 .

[4]  Bjarni V. Halldórsson,et al.  Large-scale whole-genome sequencing of the Icelandic population , 2015, Nature Genetics.

[5]  M. Bear,et al.  STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study , 2014, Journal of autism and developmental disorders.

[6]  Adam J. Schwarz,et al.  CNVs conferring risk of autism or schizophrenia affect cognition in controls , 2013, Nature.

[7]  Marcel J. T. Reinders,et al.  Hi-C Chromatin Interaction Networks Predict Co-expression in the Mouse Cortex , 2015, PLoS Comput. Biol..

[8]  Hani Z. Girgis,et al.  A High-Resolution Enhancer Atlas of the Developing Telencephalon , 2013, Cell.

[9]  T. Insel,et al.  Wesleyan University From the SelectedWorks of Charles A . Sanislow , Ph . D . 2010 Research Domain Criteria ( RDoC ) : Toward a New Classification Framework for Research on Mental Disorders , 2018 .

[10]  C. Lord,et al.  The Simons Simplex Collection: A Resource for Identification of Autism Genetic Risk Factors , 2010, Neuron.

[11]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[12]  Albert David,et al.  X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. , 2004, American journal of human genetics.

[13]  Tanya M. Teslovich,et al.  Re-sequencing Expands Our Understanding of the Phenotypic Impact of Variants at GWAS Loci , 2014, PLoS genetics.

[14]  Soher Balkhy,et al.  Mutations in Human Accelerated Regions Disrupt Cognition and Social Behavior , 2016, Cell.

[15]  Ryan L. Collins,et al.  Defining the diverse spectrum of inversions, complex structural variation, and chromothripsis in the morbid human genome , 2017, Genome Biology.

[16]  Jianxin Shi,et al.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.

[17]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[18]  D. Geschwind,et al.  Advancing the understanding of autism disease mechanisms through genetics , 2016, Nature Medicine.

[19]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[20]  Anne Boland,et al.  Bivariate association analysis in selected samples: application to a GWAS of two bone mineral density phenotypes in males with high or low BMD , 2011, European Journal of Human Genetics.

[21]  D. Goldstein,et al.  Uncovering the roles of rare variants in common disease through whole-genome sequencing , 2010, Nature Reviews Genetics.

[22]  Eric M. Morrow,et al.  Using Whole-Exome Sequencing to Identify Inherited Causes of Autism , 2013, Neuron.

[23]  Stephan J Sanders,et al.  A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.

[24]  Michael J. Owen,et al.  Cognitive Performance Among Carriers of Pathogenic Copy Number Variants: Analysis of 152,000 UK Biobank Subjects , 2017, Biological Psychiatry.

[25]  D. Hinds,et al.  Identification of 15 genetic loci associated with risk of major depression in individuals of European descent , 2016, Nature Genetics.

[26]  Cameron S. Osborne,et al.  The pluripotent regulatory circuitry connecting promoters to their long-range interacting elements , 2015, Genome research.

[27]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[28]  Stephan J Sanders,et al.  Refining the role of de novo protein truncating variants in neurodevelopmental disorders using population reference samples , 2016, Nature Genetics.

[29]  Michael J. Purcaro,et al.  The PsychENCODE project , 2015, Nature Neuroscience.

[30]  Xin Li,et al.  The impact of structural variation on human gene expression , 2016, Nature Genetics.

[31]  Stephan J Sanders,et al.  Intellectual disability is associated with increased runs of homozygosity in simplex autism. , 2013, American journal of human genetics.

[32]  Abraham A. Palmer,et al.  Genetic Background Limits Generalizability of Genotype-Phenotype Relationships , 2016, Neuron.

[33]  A. McKenna,et al.  CRISPR/Cas9-Mediated Scanning for Regulatory Elements Required for HPRT1 Expression via Thousands of Large, Programmed Genomic Deletions. , 2017, American journal of human genetics.

[34]  Wei Niu,et al.  Coexpression Networks Implicate Human Midfetal Deep Cortical Projection Neurons in the Pathogenesis of Autism , 2013, Cell.

[35]  Amina Noor,et al.  Frequency and Complexity of De Novo Structural Mutation in Autism. , 2016, American journal of human genetics.

[36]  Daning Lu,et al.  Chromosome conformation elucidates regulatory relationships in developing human brain , 2016, Nature.

[37]  Shane J. Neph,et al.  Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.

[38]  Tudor Groza,et al.  The Human Phenotype Ontology in 2017 , 2016, Nucleic Acids Res..

[39]  Minna Männikkö,et al.  Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders , 2016, Nature Neuroscience.

[40]  Christopher S. Poultney,et al.  Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci , 2015, Neuron.

[41]  Eric S. Lander,et al.  A polygenic burden of rare disruptive mutations in schizophrenia , 2014, Nature.

[42]  Alice M Stamatakis,et al.  Loss of UBE3A from TH-expressing neurons suppresses GABA co-release and enhances VTA-NAc optical self-stimulation , 2016, Nature Communications.

[43]  Robert A Harris,et al.  Mutations in BCKD-kinase Lead to a Potentially Treatable Form of Autism with Epilepsy , 2012, Science.

[44]  P. McGuffin,et al.  Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. , 2013, JAMA psychiatry.

[45]  J. Dekker,et al.  The long-range interaction landscape of gene promoters , 2012, Nature.

[46]  Giulio Genovese,et al.  Schizophrenia risk from complex variation of complement component 4 , 2016, Nature.

[47]  Rita M Cantor,et al.  Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex Families. , 2016, American journal of human genetics.

[48]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[49]  Paul T. Groth,et al.  The ENCODE (ENCyclopedia Of DNA Elements) Project , 2004, Science.

[50]  Marylyn D. Ritchie,et al.  Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study , 2016, Science.

[51]  Christopher S. Poultney,et al.  Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia , 2017, Molecular Autism.

[52]  A. Bird,et al.  Rett Syndrome: Crossing the Threshold to Clinical Translation , 2016, Trends in Neurosciences.

[53]  K. Roeder,et al.  The Autism Sequencing Consortium: Large-Scale, High-Throughput Sequencing in Autism Spectrum Disorders , 2012, Neuron.

[54]  Neva C. Durand,et al.  A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping , 2014, Cell.

[55]  R. Sandberg,et al.  Genome-wide mapping of promoter-anchored interactions with close to single-enhancer resolution , 2015, Genome Biology.

[56]  Giulio Genovese,et al.  Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia , 2016, Nature Neuroscience.

[57]  Patrick F. Sullivan,et al.  Ultra-rare disruptive and damaging mutations influence educational attainment in the general population , 2016, Nature Neuroscience.

[58]  Wei Cheng,et al.  Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects , 2016, Nature Genetics.

[59]  Peter C. Scacheri,et al.  Mutations in the noncoding genome , 2015, Current opinion in pediatrics.

[60]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[61]  M. Jarvelin,et al.  Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders , 2013, Nature Neuroscience.

[62]  Geetha Senthil,et al.  Convergence of Advances in Genomics, Team Science, and Repositories as Drivers of Progress in Psychiatric Genomics , 2015, Biological Psychiatry.

[63]  Kathryn Roeder,et al.  Rare Complete Knockouts in Humans: Population Distribution and Significant Role in Autism Spectrum Disorders , 2013, Neuron.

[64]  D. Goldstein,et al.  Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes , 2013, PLoS genetics.

[65]  Eric M. Morrow,et al.  A Genome-wide Association Study of Autism Using the Simons Simplex Collection: Does Reducing Phenotypic Heterogeneity in Autism Increase Genetic Homogeneity? , 2015, Biological Psychiatry.

[66]  D. Haussler,et al.  Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. , 2005, Genome research.

[67]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[68]  Manuel A. R. Ferreira,et al.  Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 , 2011, Nature Genetics.

[69]  G. Kirov,et al.  Copy number variation in bipolar disorder , 2015, Molecular Psychiatry.

[70]  Stephan J Sanders.  First glimpses of the neurobiology of autism spectrum disorder. , 2015, Current opinion in genetics & development.

[71]  E. Banks,et al.  De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.

[72]  Łukasz M. Boryń,et al.  Genome-Wide Quantitative Enhancer Activity Maps Identified by STARR-seq , 2013, Science.